Physician profile
Kathy Biddinger
NPI 1669434130
$1,433.11
in general payments reported to CMS, 2019-2025
10 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $24.78 · 2021: $214 · 2022: $262 · 2023: $202 · 2024: $319 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712 · Consulting Fee: $20.00 · Entertainment: $18.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.70 |
| Consulting Fee | $20.00 |
| Entertainment | $18.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $513.83 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $294.10 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $241.10 | 2022-2025 | Infuse |
| Lkc Technologies, INC. | $117.62 | 2024-2025 | |
| Maculogix, INC. | $100.00 | 2021 | |
| Alcon Vision LLC | $79.41 | 2022 | |
| Abbvie INC. | $28.16 | 2022-2025 | |
| Lombart Brothers, INC. | $22.32 | 2024 | Opd-III |
| Optos, INC. | $18.65 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $17.92 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Biddinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.